Document Details
Form
Filing Date
Jun 20, 2024
Document Date
Jun 18, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Inozyme Pharma, Inc.
Issuer
INOZYME PHARMA, INC.
Filer
Edwards Martin